Free Trial

Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Villere ST Denis J & Co. LLC

Option Care Health logo with Medical background

Villere ST Denis J & Co. LLC decreased its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 32.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 906,758 shares of the company's stock after selling 437,850 shares during the quarter. Option Care Health makes up 3.1% of Villere ST Denis J & Co. LLC's holdings, making the stock its 10th largest position. Villere ST Denis J & Co. LLC owned about 0.55% of Option Care Health worth $31,691,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of OPCH. Allspring Global Investments Holdings LLC boosted its position in Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock worth $52,459,000 after purchasing an additional 1,500,963 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares during the period. Wealthquest Corp purchased a new stake in Option Care Health during the first quarter worth $66,000. Sheets Smith Wealth Management increased its holdings in Option Care Health by 2.6% in the first quarter. Sheets Smith Wealth Management now owns 24,481 shares of the company's stock valued at $856,000 after buying an additional 625 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. raised its holdings in Option Care Health by 33.0% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 49,132 shares of the company's stock worth $1,717,000 after purchasing an additional 12,180 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $35.50.

View Our Latest Research Report on OPCH

Option Care Health Price Performance

NASDAQ:OPCH opened at $32.25 on Friday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The stock has a market cap of $5.28 billion, a PE ratio of 26.01, a P/E/G ratio of 1.93 and a beta of 0.74. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54. The stock has a 50 day moving average price of $32.06 and a 200 day moving average price of $30.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the company earned $0.26 EPS. The company's revenue for the quarter was up 16.3% on a year-over-year basis. Equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines